JP Morgan Chase’s NovoCure NVCR Stock Holding History

JP Morgan Chase’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-20,600	Closed	-$614K	–	7616
2024 Q4	$614K	Sell	20,600 -69,600	-77%	-$1.47M	﹤0.01%	4926
2024 Q3	$1.41M	Buy	+90,200	New	+$1.64M	﹤0.01%	4256
2024 Q1	–	Sell	-2,400	Closed	-$35.8K	–	7743
2023 Q4	$35.8K	Hold	2,400	–	–	﹤0.01%	6108
2023 Q3	$38.8K	Hold	2,400	–	–	﹤0.01%	5879
2023 Q2	$99.6K	Hold	2,400	–	–	﹤0.01%	5463
2023 Q1	$144K	Sell	2,400 -38,900	-94%	-$3.11M	﹤0.01%	5257
2022 Q4	$3.03M	Buy	41,300 +11,100	+37%	+$835K	﹤0.01%	3237
2022 Q3	$2.29M	Hold	30,200	–	–	﹤0.01%	3356
2022 Q2	$2.1M	Sell	30,200 -23,700	-44%	-$1.79M	﹤0.01%	3505
2022 Q1	$4.47M	Buy	+53,900	New	+$3.97M	﹤0.01%	3097
2021 Q1	–	Sell	-62,400	Closed	-$10.8M	–	6254
2020 Q4	$10.8M	Buy	+62,400	New	+$8.54M	﹤0.01%	2150
2020 Q2	–	Sell	-20,000	Closed	-$1.35M	–	5594
2020 Q1	$1.35M	Sell	20,000 -93,000	-82%	-$7.35M	﹤0.01%	3227
2019 Q4	$9.52M	Sell	113,000 -50,000	-31%	-$4.04M	﹤0.01%	2152
2019 Q3	$12.2M	Hold	163,000	–	–	﹤0.01%	1972
2019 Q2	$9.92M	Hold	163,000	–	–	﹤0.01%	2118
2019 Q1	$7.85M	Hold	163,000	–	–	﹤0.01%	2250
2018 Q4	$5.46M	Buy	163,000 +133,000	+443%	+$4.86M	﹤0.01%	2508
2018 Q3	$1.57M	Buy	+30,000	New	+$1.19M	﹤0.01%	3628

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

JP Morgan Chase's NVCR Position: Q2 2026 in Review

JP Morgan Chase increased its NovoCure (NVCR) stake by 80% in Q2 2026, buying an estimated $11.2M and bringing the position to 1,671,082 shares worth $25.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1991.

JP Morgan Chase first reported a position in NVCR in Q4 2015 and has held it in 37 quarters since. The position peaked at $31.9M in Q4 2020. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

JP Morgan Chase held 1,671,082 shares of NovoCure worth $25.9M as of Q2 2026.
JP Morgan Chase bought 740,916 NovoCure shares in Q2 2026, an estimated $11.2M.
NovoCure made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #1991 holding.
JP Morgan Chase first reported a position in NovoCure in Q4 2015 and has held it in 37 quarters since.
JP Morgan Chase's NovoCure position peaked at $31.9M in Q4 2020.
218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.